Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 18 Sep 2023

Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment

in Pharmacoepidemiology

Patricia Marques Soares Valente
Paula Nogueira da Silva
Licínio Esmeraldo da Silva
Wolney de Andrade Martins
Selma Rodrigues de Castilho

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1099545

1,477 views
2 citations

Original Research

Published on 15 Sep 2023

Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia

in Pharmacoepidemiology

Maria Giner-Soriano
Dan Ouchi
Roser Vives
Carles Vilaplana-Carnerero
Andrea Molina
Antoni Vallano
Rosa Morros

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237454

2,192 views
3 citations

Original Research

Published on 14 Sep 2023

Epirubicin and gait apraxia: a real-world data analysis of the FDA Adverse Event Reporting System database

in Pharmacoepidemiology

Wei Wang
Xin Guan
Shuang Wang
Lipeng Shi
Yanfei Zhu
Pengbo Hua
Qiang Guo
Jingqi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1249845

2,274 views
2 citations

Original Research

Published on 14 Sep 2023

Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system

in Pharmacoepidemiology

Rui Xiong
Jing Lei
Sicen Pan
Hong Zhang
Yongtao Tong
Wei Wu
Yi Huang
Xiaodan Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1226086

2,602 views
3 citations

Editorial

Published on 12 Sep 2023

Editorial: Women in pharmacoepidemiology: 2021

in Pharmacoepidemiology

Luciane Cruz Lopes
Daniela C. Moga
Tatiane Da Silva Dal Pizzol
Natasa Gisev
Bita Mesgarpour
Anick Bérard

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1278768

1,233 views

Original Research

Published on 07 Sep 2023

Association between marijuana use and kidney stone: a cross-sectional study of NHANES 2009 to 2018

in Pharmacoepidemiology

Xingpeng Di
Liyuan Xiang
Menghua Wang
Xin Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1214647

32,222 views
2 citations

Review

Published on 23 Aug 2023

Multisystem inflammatory syndrome drug treatment in countries with different income profiles: a scoping review

in Pharmacoepidemiology

Luis Phillipe Nagem Lopes
Lidiane Gomes da Cunha
Alice Ramos Oliveira Silva
Marcelo Gerardin Poirot Land
Adriana Rodrigues Fonseca
Luciane Cruz Lopes
Elisangela Costa Lima

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228986

1,793 views
1 citation

Original Research

Published on 17 Aug 2023

Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis

in Pharmacoepidemiology

Carlos E. Durán
Judit Riera-Arnau
Shahab Abtahi
Romin Pajouheshnia
Vjola Hoxhaj
Magdalena Gamba
Ema Alsina
Mar Martin-Perez
Patricia Garcia-Poza
Ana Llorente-Garcia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1207976

4,063 views
4 citations

General Commentary

Published on 16 Aug 2023

Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous reports submitted to FAERS

in Pharmacoepidemiology

Jeanne M. Schilder
Amanda Golembesky
Tirza Areli Calderón Boyle
Gui Lan Ye
Judi Kuplast

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1241524

2,581 views
4 citations

Original Research

Published on 14 Aug 2023

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system

in Pharmacoepidemiology

Wei Wei
Li Chen
Hui Zhou
Jinfeng Liu
Yue Zhang
Shiyu Feng
Yingtao Bai
Yanen Leng
En Chang
Liang Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1208456

7,613 views
8 citations

Original Research

Published on 10 Aug 2023

Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer

in Pharmacoepidemiology

George S. Q. Tan
Edoardo Botteri
Stephen Wood
Erica K. Sloan
Jenni Ilomäki

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1227330

2,190 views

Systematic Review

Published on 27 Jul 2023

Efficacy of opioids for traumatic pain in the emergency department: a systematic review and Bayesian network meta-analysis

in Pharmacoepidemiology

Yawen Fu
Qiang Liu
Hu Nie

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1209131

3,300 views
2 citations

Original Research

Published on 24 Jul 2023

Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess

in Pharmacoepidemiology

Mingming Li
Ruxu You
Yuyong Su
Hongbo Zhou
Shiwei Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1169327

5,514 views
11 citations

Original Research

Published on 18 Jul 2023

Opioid prescription patterns in the province of Las Palmas, Canary Islands, Spain (2016–2020): differences between urban and rural areas

in Pharmacoepidemiology

Alexis Oliva
Patricia González de Chavez
Sandra Dévora
Susana Abdala

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1184457

2,966 views
2 citations

Original Research

Published on 12 Jul 2023

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database

in Pharmacoepidemiology

Hui Zhao
Jun-Min Li
Zi-Ran Li
Qian Zhang
Ming-Kang Zhong
Ming-Ming Yan
Xiao-Yan Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1182113

5,487 views
8 citations

Original Research

Published on 12 Jul 2023

Assessment of the impact of good pharmacy practices training among drug dispensers in Bangladesh

in Pharmacoepidemiology

Sunjida Binta Ali
Nantu Chakma
Md. Saimul Islam
Raian Amzad
Md. lftakhar Hassan Khan
Md. Aziulla
Tanisha Momtaz
Abul Kalam Azad
Zaheer-Ud-Din Babar
Aliya Naheed

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1139632

4,073 views
4 citations

Navigation group

Articles

Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment

Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia

Epirubicin and gait apraxia: a real-world data analysis of the FDA Adverse Event Reporting System database

Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system

Editorial: Women in pharmacoepidemiology: 2021

Association between marijuana use and kidney stone: a cross-sectional study of NHANES 2009 to 2018

Multisystem inflammatory syndrome drug treatment in countries with different income profiles: a scoping review

Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis

Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous reports submitted to FAERS

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system

Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer

Efficacy of opioids for traumatic pain in the emergency department: a systematic review and Bayesian network meta-analysis

Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess

Opioid prescription patterns in the province of Las Palmas, Canary Islands, Spain (2016–2020): differences between urban and rural areas

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database

Assessment of the impact of good pharmacy practices training among drug dispensers in Bangladesh